| Literature DB >> 34884266 |
Dominika Ochnik1, Aleksandra M Rogowska2, Cezary Kuśnierz3, Monika Jakubiak4, Magdalena Wierzbik-Strońska1, Astrid Schütz5, Marco J Held5, Ana Arzenšek6, Iuliia Pavlova7, Elena V Korchagina8,9, Imran Aslan10, Orhan Çınar11.
Abstract
This study aimed to reveal differences in exposure to coronavirus disease (COVID-19) during the first (W1) and the second (W2) waves of the pandemic in six countries among university students and to show the prevalence and associations between exposure to COVID-19 and coronavirus-related post-traumatic stress syndrome (PTSD) risk during W2. The repeated cross-sectional study was conducted among university students from Germany, Poland, Russia, Slovenia, Turkey, and Ukraine (W1: n = 1684; W2: n = 1741). Eight items measured exposure to COVID-19 (regarding COVID-19 symptoms, testing, hospitalizing quarantine, infected relatives, death of relatives, job loss, and worsening economic status due to the COVID-19 pandemic). Coronavirus-related PTSD risk was evaluated by PCL-S. The exposure to COVID-19 symptoms was higher during W2 than W1 among students from all countries, except Germany, where, in contrast, the increase in testing was the strongest. Students from Poland, Turkey, and the total sample were more frequently hospitalized for COVID-19 in W2. In these countries, and Ukraine, students were more often in quarantine. In all countries, participants were more exposed to infected friends/relatives and the loss of a family member due to COVID-19 in W2 than W1. The increase in job loss due to COVID-19 was only noted in Ukraine. Economic status during W2 only worsened in Poland and improved in Russia. This was due to the significant wave of restrictions in Russia and more stringent restrictions in Poland. The prevalence of coronavirus-related PTSD risk at three cutoff scores (25, 44, and 50) was 78.20%, 32.70%, and 23.10%, respectively. The prediction models for different severity of PTSD risk differed. Female gender, a prior diagnosis of depression, a loss of friends/relatives, job loss, and worsening economic status due to the COVID-19 were positively associated with high and very high coronavirus-related PTSD risk, while female gender, a prior PTSD diagnosis, experiencing COVID-19 symptoms, testing for COVID-19, having infected friends/relatives and worsening economic status were associated with moderate risk.Entities:
Keywords: COVID-19; PTSD; cross-national; exposure to COVID-19; students
Year: 2021 PMID: 34884266 PMCID: PMC8658425 DOI: 10.3390/jcm10235564
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Figures present the following data in six countries (Germany, Poland, Russia, Slovenia, Ukraine, and Turkey) during the first (W1) and the second (W2) wave of the COVID-19 pandemic: (a) stringency of restrictions; (b) mean number of new daily cases of COVID-19; (c) mean number of new daily COVID-19-related deaths.
Sociodemographic characteristics and previous diagnosis of depression, anxiety, and PTSD of the study sample in the six countries.
| Demographic | TOTAL | Germany | Poland | Russia | Slovenia | Turkey | Ukraine | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % |
| % |
| % |
| % |
| % | |
|
| ||||||||||||||
| Gender | ||||||||||||||
| Women | 1174 | 69.70 | 193 | 71.50 | 220 | 73.40 | 193 | 67.00 | 178 | 85.20 | 173 | 55.80 | 217 | 70.00 |
| Men | 504 | 29.90 | 75 | 27.80 | 80 | 26.60 | 92 | 32.20 | 31 | 14.80 | 133 | 42.90 | 93 | 30.00 |
| Did not want to say | 6 | 0.40 | 2 | 0.70 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 4 | 1.30 | 0 | 0.00 |
| Place of residence | ||||||||||||||
| Village | 449 | 26.70 | 53 | 19.60 | 140 | 46.80 | 7 | 2.50 | 85 | 40.70 | 52 | 16.80 | 112 | 36.10 |
| Town | 572 | 34.00 | 177 | 65.60 | 94 | 31.20 | 81 | 28.40 | 65 | 31.10 | 41 | 13.20 | 114 | 36.80 |
| City | 481 | 28.60 | 33 | 12.20 | 61 | 20.30 | 171 | 60.00 | 40 | 31.10 | 101 | 32.60 | 75 | 24.20 |
| Agglomeration | 182 | 10.70 | 7 | 2.60 | 5 | 1.70 | 26 | 9.10 | 19 | 9.10 | 116 | 37.40 | 9 | 2.90 |
| Level of study | ||||||||||||||
| Bachelor | 1269 | 75.30 | 137 | 50.70 | 170 | 56.80 | 245 | 86.10 | 143 | 68.40 | 283 | 91.30 | 291 | 93.90 |
| Master | 340 | 20.20 | 96 | 36.60 | 130 | 43.20 | 33 | 11.60 | 61 | 29.20 | 1 | 0.30 | 19 | 6.10 |
| Postgraduate | 67 | 4.00 | 35 | 13.00 | 0 | 0.00 | 7 | 2.50 | 0 | 0.00 | 25 | 8.10 | 0 | 0.00 |
| Doctoral | 8 | 0.50 | 2 | 0.70 | 0 | 0.00 | 0 | 0.00 | 5 | 2.40 | 1 | 0.30 | 0 | 0.00 |
| TOTAL | 1684 | 100 | 270 | 100 | 300 | 100 | 285 | 100 | 209 | 100 | 310 | 100 | 310 | 100 |
|
| ||||||||||||||
| Gender | ||||||||||||||
| Women | 1275 | 73.20 | 158 | 57.20 | 308 | 90.30 | 204 | 74.50 | 161 | 78.20 | 215 | 68.90 | 229 | 69.00 |
| Men | 454 | 26.10 | 116 | 42.00 | 29 | 8.50 | 70 | 25.50 | 45 | 21.80 | 97 | 31.10 | 97 | 29.20 |
| Did not want to say | 12 | 0.70 | 2 | 0.70 | 4 | 1.20 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Place of residence | ||||||||||||||
| Village | 442 | 25.40 | 48 | 17.40 | 145 | 42.80 | 10 | 3.60 | 66 | 32.00 | 61 | 19.60 | 111 | 33.40 |
| Town | 587 | 33.70 | 173 | 62.70 | 140 | 41.10 | 68 | 24.80 | 80 | 38.80 | 13 | 4.20 | 113 | 34.00 |
| City | 559 | 32.10 | 41 | 14.90 | 50 | 14.70 | 181 | 66.10 | 52 | 25.20 | 132 | 42.30 | 103 | 31.00 |
| Agglomeration | 149 | 8.60 | 10 | 3.60 | 5 | 1.50 | 15 | 5.50 | 8 | 3.90 | 106 | 34.00 | 5 | 1.50 |
| Other | 4 | 0.20 | 4 | 1.40 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Level of study | ||||||||||||||
| Bachelor | 1324 | 75.90 | 134 | 48.60 | 220 | 64.50 | 232 | 84.70 | 146 | 70.90 | 291 | 93.30 | 301 | 90.70 |
| Master | 384 | 22.10 | 122 | 44.20 | 121 | 35.50 | 38 | 13.90 | 60 | 29.10 | 12 | 3.80 | 31 | 9.30 |
| Postgraduate | 23 | 1.30 | 19 | 6.90 | 0 | 0.00 | 4 | 1.50 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Doctoral | 10 | 0.70 | 1 | 0.40 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 9 | 2.90 | 0 | 0.00 |
| Prior diagnosis | ||||||||||||||
| Depression | 356 | 20.40 | 38 | 13.80 | 36 | 10.60 | 38 | 13.90 | 18 | 8.70 | 154 | 49.40 | 72 | 21.70 |
| Anxiety | 287 | 16.50 | 18 | 6.50 | 36 | 10.60 | 37 | 13.50 | 25 | 12.10 | 106 | 34.00 | 65 | 19.60 |
| PTSD | 205 | 11.80 | - | - | 8 | 2.30 | 18 | 6.60 | 3 | 1.50 | 124 | 39.70 | 52 | 15.70 |
| TOTAL | 1741 | 100 | 276 | 100 | 341 | 100 | 285 | 100 | 209 | 100 | 310 | 100 | 310 | 100 |
Note. W1—first wave of the COVID-19 pandemic (May–June 2020), W2—the second wave of the COVID-19 pandemic (mid-October–December 2020).
Comparison of proportions of university students who experienced exposure to the coronavirus pandemic during the first wave W1 (May–June 2020) and the second wave W2 (October–December 2020) of the COVID-19 pandemic.
| Self-Reported Exposure | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Exposure Item | No | Yes | Pearson’s | |||||||
| Sample | Wave |
| % |
| % |
| χ2(1) |
| ϕ | |
| 1. Experiencing Symptoms of Coronavirus Infection | ||||||||||
| Total | W1 | 1486 | 88.24 | 198 | 11.76 | 1684 | 162.29 | <0.001 | 0.22 | |
| W2 | 1229 | 70.59 | 512 | 29.41 | 1741 | |||||
| Germany | W1 | 218 | 80.74 | 52 | 19.26 | 270 | 3.27 | 0.071 | 0.08 | |
| W2 | 205 | 74.28 | 71 | 25.72 | 276 | |||||
| Poland | W1 | 274 | 91.33 | 26 | 8.67 | 300 | 22.13 | <0.001 | 0.19 | |
| W2 | 265 | 77.71 | 76 | 22.29 | 341 | |||||
| Russia | W1 | 237 | 83.16 | 48 | 16.84 | 285 | 21.66 | <0.001 | 0.20 | |
| W2 | 181 | 66.06 | 93 | 33.94 | 274 | |||||
| Slovenia | W1 | 181 | 86.60 | 28 | 13.40 | 209 | 10.75 | 0.001 | 0.16 | |
| W2 | 152 | 73.79 | 54 | 26.21 | 206 | |||||
| Turkey | W1 | 288 | 92.90 | 22 | 7.10 | 310 | 53.22 | <0.001 | 0.29 | |
| W2 | 219 | 70.19 | 93 | 29.81 | 312 | |||||
| Ukraine | W1 | 288 | 92.90 | 22 | 7.10 | 310 | 84.77 | <0.001 | 0.36 | |
| W2 | 207 | 62.35 | 125 | 37.65 | 332 | |||||
| 2. Testing for Coronavirus | ||||||||||
| Total | W1 | 1611 | 95.67 | 73 | 4.33 | 1684 | 176.23 | <0.001 | 0.23 | |
| W2 | 1411 | 81.05 | 330 | 18.95 | 1741 | |||||
| Germany | W1 | 259 | 95.93 | 11 | 4.07 | 270 | 51.31 | <0.001 | 0.31 | |
| W2 | 204 | 73.91 | 72 | 26.09 | 276 | |||||
| Poland | W1 | 296 | 98.67 | 4 | 1.33 | 300 | 18.61 | <0.001 | 0.17 | |
| W2 | 310 | 90.91 | 31 | 9.09 | 341 | |||||
| Russia | W1 | 253 | 88.77 | 32 | 11.23 | 285 | 23.52 | <0.001 | 0.21 | |
| W2 | 199 | 72.63 | 75 | 27.37 | 274 | |||||
| Slovenia | W1 | 200 | 95.69 | 9 | 4.31 | 209 | 6.86 | 0.009 | 0.13 | |
| W2 | 183 | 88.83 | 23 | 11.17 | 206 | |||||
| Turkey | W1 | 299 | 96.45 | 11 | 3.55 | 310 | 48.97 | <0.001 | 0.28 | |
| W2 | 242 | 77.56 | 70 | 22.44 | 312 | |||||
| Ukraine | W1 | 304 | 98.06 | 6 | 1.94 | 310 | 44.18 | <0.001 | 0.26 | |
| W2 | 273 | 82.23 | 59 | 17.77 | 332 | |||||
| 3. Hospitalizing for Coronavirus | ||||||||||
| Total | W1 | 1679 | 99.70 | 5 | 0.30 | 1684 | 9.40 | <0.001 | 0.05 | |
| W2 | 1719 | 98.79 | 21 | 1.21 | 1741 | |||||
| Germany | W1 | 270 | 100.00 | 0 | 0.00 | 270 | 1.96 | 0.161 | 0.06 | |
| W2 | 274 | 99.28 | 2 | 0.72 | 276 | |||||
| Poland | W1 | 300 | 100.00 | 0 | 0.00 | 300 | 6.23 | 0.013 | 0.10 | |
| W2 | 334 | 97.95 | 7 | 2.05 | 341 | |||||
| Russia | W1 | 283 | 99.30 | 2 | 0.70 | 285 | 1.92 | 0.166 | −0.06 | |
| W2 | 273 | 100.00 | 0 | 0.00 | 273 | |||||
| Slovenia | W1 | 209 | 100.00 | 0 | 0.00 | 209 | 0.00 | 1.00 | 0.00 | |
| W2 | 206 | 100.00 | 0 | 0.00 | 206 | |||||
| Turkey | W1 | 309 | 99.68 | 1 | 0.32 | 310 | 4.52 | 0.034 | 0.09 | |
| W2 | 305 | 97.76 | 7 | 2.24 | 312 | |||||
| Ukraine | W1 | 308 | 99.35 | 2 | 0.65 | 310 | 1.10 | 0.294 | 0.04 | |
| W2 | 327 | 98.49 | 5 | 1.51 | 332 | |||||
| 4. Being in a Strict Quarantine for at Least 14 Days | ||||||||||
| Total | W1 | 1575 | 93.53 | 109 | 6.47 | 1684 | 18.82 | <0.001 | 0.07 | |
| W2 | 1556 | 89.37 | 185 | 10.63 | 1741 | |||||
| Germany | W1 | 246 | 91.11 | 24 | 8.89 | 270 | 1.46 | 0.227 | −0.05 | |
| W2 | 259 | 93.84 | 17 | 6.16 | 276 | |||||
| Poland | W1 | 294 | 98.00 | 6 | 2.00 | 300 | 9.86 | 0.002 | 0.12 | |
| W2 | 316 | 92.67 | 25 | 7.33 | 341 | |||||
| Russia | W1 | 254 | 89.12 | 31 | 10.88 | 285 | 1.44 | 0.230 | 0.05 | |
| W2 | 235 | 85.77 | 39 | 14.23 | 273 | |||||
| Slovenia | W1 | 203 | 97.13 | 6 | 2.87 | 209 | 1.61 | 0.205 | 0.06 | |
| W2 | 195 | 94.66 | 11 | 5.34 | 206 | |||||
| Turkey | W1 | 293 | 94.52 | 17 | 5.48 | 310 | 13.84 | <0.001 | 0.15 | |
| W2 | 267 | 85.58 | 45 | 14.42 | 312 | |||||
| Ukraine | W1 | 285 | 91.94 | 25 | 8.06 | 310 | 6.50 | 0.011 | 0.10 | |
| W2 | 284 | 85.54 | 48 | 14.46 | 332 | |||||
| 5. Friends or Relatives Were Infected | ||||||||||
| Total | W1 | 1441 | 85.57 | 243 | 14.43 | 1684 | 516.36 | <0.001 | 0.39 | |
| W2 | 854 | 49.05 | 887 | 50.95 | 1741 | |||||
| Germany | W1 | 207 | 76.67 | 63 | 23.33 | 270 | 4.59 | 0.032 | 0.09 | |
| W2 | 189 | 68.48 | 87 | 31.52 | 276 | |||||
| Poland | W1 | 277 | 92.33 | 23 | 7.67 | 300 | 166.08 | <0.001 | 0.51 | |
| W2 | 151 | 44.28 | 190 | 55.72 | 341 | |||||
| Russia | W1 | 225 | 78.95 | 60 | 21.05 | 285 | 67.61 | <0.001 | 0.35 | |
| W2 | 124 | 45.26 | 150 | 54.74 | 273 | |||||
| Slovenia | W1 | 195 | 93.30 | 14 | 6.70 | 209 | 32.17 | <0.001 | 0.28 | |
| W2 | 149 | 72.33 | 57 | 27.67 | 206 | |||||
| Turkey | W1 | 242 | 78.06 | 68 | 21.94 | 310 | 199.20 | <0.001 | 0.57 | |
| W2 | 67 | 21.47 | 245 | 78.53 | 312 | |||||
| Ukraine | W1 | 295 | 95.16 | 15 | 4.84 | 310 | 148.84 | <0.001 | 0.48 | |
| W2 | 174 | 52.41 | 158 | 47.59 | 332 | |||||
| 6. Friends or Relatives Died Due to Coronavirus | ||||||||||
| Total | W1 | 1643 | 97.57 | 41 | 2.43 | 1684 | 131.47 | <0.001 | 0.19 | |
| W2 | 1516 | 87.08 | 225 | 12.92 | 1741 | |||||
| Germany | W1 | 266 | 98.52 | 4 | 1.48 | 270 | 7.20 | 0.007 | 0.11 | |
| W2 | 260 | 94.20 | 16 | 5.80 | 276 | |||||
| Poland | W1 | 300 | 100.00 | 0 | 0.00 | 300 | 19.10 | <0.001 | 0.17 | |
| W2 | 320 | 93.84 | 21 | 6.16 | 341 | |||||
| Russia | W1 | 269 | 94.39 | 16 | 5.61 | 285 | 13.34 | <0.001 | 0.15 | |
| W2 | 233 | 85.04 | 41 | 14.96 | 273 | |||||
| Slovenia | W1 | 207 | 99.04 | 2 | 0.96 | 209 | 6.57 | 0.007 | 0.13 | |
| W2 | 195 | 94.66 | 11 | 5.34 | 206 | |||||
| Turkey | W1 | 292 | 94.19 | 18 | 5.81 | 310 | 82.52 | <0.001 | 0.36 | |
| W2 | 202 | 64.74 | 110 | 35.26 | 312 | |||||
| Ukraine | W1 | 309 | 99.68 | 1 | 0.32 | 310 | 22.44 | <0.001 | 0.19 | |
| W2 | 306 | 92.17 | 26 | 7.83 | 332 | |||||
| 7. Job Loss Because of the Coronavirus | ||||||||||
| Total | W1 | 1157 | 68.71 | 527 | 31.29 | 1684 | 8.09 | 0.004 | −0.05 | |
| W2 | 1273 | 73.12 | 468 | 26.88 | 1741 | |||||
| Germany | W1 | 208 | 77.04 | 62 | 22.96 | 270 | 0.57 | 0.452 | 0.03 | |
| W2 | 205 | 74.28 | 71 | 25.72 | 276 | |||||
| Poland | W1 | 217 | 72.33 | 83 | 27.67 | 300 | 0.00 | 0.977 | 0.00 | |
| W2 | 247 | 72.43 | 94 | 27.57 | 341 | |||||
| Russia | W1 | 227 | 79.65 | 58 | 20.35 | 285 | 0.73 | 0.393 | −0.04 | |
| W2 | 226 | 82.48 | 48 | 17.52 | 273 | |||||
| Slovenia | W1 | 160 | 76.56 | 49 | 23.44 | 209 | 0.01 | 0.935 | 0.00 | |
| W2 | 157 | 76.21 | 49 | 23.79 | 206 | |||||
| Turkey | W1 | 162 | 52.26 | 148 | 47.74 | 310 | 3.12 | 0.077 | −0.07 | |
| W2 | 185 | 59.29 | 127 | 40.71 | 312 | |||||
| Ukraine | W1 | 183 | 59.03 | 127 | 40.97 | 310 | 21.70 | <0.001 | −0.18 | |
| W2 | 253 | 76.20 | 79 | 23.80 | 332 | |||||
| 8. Economic Status Worsened Due to the Pandemic | ||||||||||
| Total | W1 | 747 | 44.36 | 937 | 55.64 | 1684 | 0.02 | 0.885 | 0.00 | |
| W2 | 768 | 44.11 | 973 | 55.89 | 1741 | |||||
| Germany | W1 | 202 | 74.81 | 68 | 25.19 | 270 | 1.19 | 0.275 | 0.05 | |
| W2 | 195 | 70.65 | 81 | 29.35 | 276 | |||||
| Poland | W1 | 120 | 40.00 | 180 | 60.00 | 300 | 10.55 | 0.001 | 0.13 | |
| W2 | 95 | 27.86 | 246 | 72.14 | 341 | |||||
| Russia | W1 | 124 | 43.51 | 161 | 56.49 | 285 | 11.78 | <0.001 | −0.15 | |
| W2 | 159 | 58.03 | 115 | 41.97 | 273 | |||||
| Slovenia | W1 | 104 | 49.76 | 105 | 50.24 | 209 | 0.30 | 0.587 | −0.03 | |
| W2 | 108 | 52.43 | 98 | 47.57 | 206 | |||||
| Turkey | W1 | 109 | 35.16 | 201 | 64.84 | 310 | 0.08 | 0.783 | −0.01 | |
| W2 | 113 | 36.22 | 199 | 63.78 | 312 | |||||
| Ukraine | W1 | 88 | 28.39 | 222 | 71.61 | 310 | 0.10 | 0.752 | −0.01 | |
| W2 | 98 | 29.52 | 234 | 70.48 | 332 | |||||
Descriptive statistics for coronavirus-related PTSD risk among university students in six countries during the second wave (October–December 2020) of the COVID-19 pandemic.
| 95% CI | Cronbach’s | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sample | N | Range | M | LL | UL | SD | Skewness | Kurtosis | α |
| Total | 1741 | 17–85 | 38.08 | 37.36 | 38.81 | 15.49 | 0.73 | −0.29 | 0.94 |
Note. M = mean; CI = confidence interval; LL = lower limit; UL = upper limit; SD = standard deviation.
Prevalence of coronavirus-related PTSD risk among university students in six countries during the second wave (October–December 2020) of the COVID-19 pandemic (N = 1741).
| Cutoff Points for Coronavirus-Related PTSD Risk in the PCL-S | Frequencies of PTSD Risk among University Students from Various Countries | |||
|---|---|---|---|---|
| No PTSD Risk | PTSD Risk | |||
|
| % |
| % | |
| Cutoff Point 25 (moderate risk) | 380 | 21.80 | 1361 | 78.20 |
| Cutoff Point 44 (high risk) | 1171 | 67.30 | 570 | 32.70 |
| Cutoff Point 50 (very high risk) | 1339 | 76.90 | 402 | 23.10 |
Results of logistic regression for coronavirus-related PTSD risk among university students during the second wave of the COVID-19 pandemic (W2) (N = 1741).
| Model 1: Moderate Risk | Model 2: High Risk | Model 3: Very High Risk | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (PCL Cut−Off Point = 25) | (PCL Cut−Off Point = 44) | (PCL Cut−Off Point = 50) | |||||||||||||
| Variable | B | SE B | Χ2(1) | AOR | (95% CI) | B | SE B | Χ2(1) | AOR | (95% CI) | B | SE B | Χ2(1) | AOR | (95% CI) |
| Constant | −0.18 | 0.16 | 1.26 | 0.83 | −2.12 | 0.18 | 135.88 | 0.12 *** | −2.51 | 0.21 | 148.56 | 0.08 *** | |||
| Gender | 0.66 | 0.15 | 19.35 | 1.94 *** | (1.44, 2.60) | 0.69 | 0.15 | 20.54 | 2.00 *** | (1.48, 2.69) | 0.57 | 0.17 | 11.35 | 1.78 *** | (1.27, 2.48) |
| Diagnosis of: | |||||||||||||||
| Depression | 0.14 | 0.29 | 0.23 | 1.15 | (0.66, 2.01) | 0.48 | 0.22 | 4.72 | 1.61* | (1.05, 2.47) | 0.52 | 0.23 | 4.87 | 1.68* | (1.06, 2.65) |
| Anxiety | 0.19 | 0.29 | 0.43 | 1.21 | (0.68, 2.16) | −0.04 | 0.23 | 0.02 | 0.96 | (0.62, 1.51) | −0.10 | 0.25 | 0.15 | 0.91 | (0.56, 1.47) |
| PTSD | 1.10 | 0.37 | 8.70 | 3.01 ** | (1.45, 6.25) | 0.37 | 0.24 | 2.31 | 1.45 | (0.90, 2.33) | 0.53 | 0.26 | 4.21 | 1.70 * | (1.02, 2.81) |
| Exposure to COVID−19 | |||||||||||||||
| 1. Symptoms | 0.49 | 0.17 | 7.92 | 1.63 ** | (1.16, 2.29) | 0.27 | 0.14 | 3.81 | 1.31 | (1.00, 1.72) | 0.23 | 0.15 | 2.23 | 1.25 | (0.93, 1.69) |
| 2. Testing | −0.40 | 0.20 | 4.04 | 0.67 * | (0.46, 0.99) | −0.13 | 0.17 | 0.59 | 0.87 | (0.62, 1.23) | 0.02 | 0.19 | 0.01 | 1.02 | (0.70, 1.48) |
| 3. Hospitalization | 0.22 | 0.70 | 0.09 | 1.24 | (0.31, 4.94) | −0.52 | 0.53 | 0.96 | 0.60 | (0.21, 1.68) | −0.69 | 0.58 | 1.44 | 0.50 | (0.16, 1.55) |
| 4. Strict quarantine for at least 14 days | −0.38 | 0.25 | 2.33 | 0.68 | (0.42, 1.12) | 0.12 | 0.21 | 0.32 | 1.12 | (0.75, 1.69) | 0.03 | 0.23 | 0.02 | 1.03 | (0.66, 1.61) |
| 5. Friends or relatives infected | 0.42 | 0.15 | 8.24 | 1.52 ** | (1.14, 2.02) | 0.00 | 0.13 | 0.00 | 1.00 | (0.78, 1.29) | −0.14 | 0.14 | 0.92 | 0.87 | (0.66, 1.15) |
| 6. Death of friends or relatives | 0.23 | 0.24 | 0.91 | 1.26 | (0.79, 2.00) | 0.53 | 0.17 | 9.54 | 1.71 ** | (1.22, 2.39) | 0.64 | 0.18 | 12.19 | 1.89 *** | (1.32, 2.70) |
| 7. Job loss | 0.32 | 0.18 | 3.36 | 1.38 | (0.98, 1.95) | 0.45 | 0.13 | 11.25 | 1.56 ** | (1.20, 2.03) | 0.60 | 0.14 | 17.52 | 1.82 *** | (1.37, 2.41) |
| 8. Economic status worsened | 0.93 | 0.14 | 43.46 | 2.52 *** | (1.92, 3.32) | 0.65 | 0.13 | 24.93 | 1.91 *** | (1.48, 2.46) | 0.59 | 0.15 | 15.96 | 1.80 *** | (1.35, 2.39) |
* p < 0.05; ** p < 0.01; *** p < 0.001.